News Releases

News Releases

Keyword Search

Date Title  
12/17/19
Optinose Announces Peer-Reviewed Publication of the Fourth Major XHANCE Registration Trial
Printer Friendly Version
11/26/19
Optinose to Present at the Piper Jaffray 31st Annual Healthcare Conference
Printer Friendly Version
11/21/19
Optinose Announces Pricing of Public Offering of Common Stock
Printer Friendly Version
11/20/19
Optinose Announces Proposed Public Offering of Common Stock
Printer Friendly Version
11/12/19
Optinose Reports Third Quarter 2019 Financial Results and Recent Operational Highlights
Printer Friendly Version
11/01/19
Optinose to Report Third Quarter 2019 Financial Results and Corporate Updates on November 12, 2019
Printer Friendly Version
10/04/19
Optinose Appoints Michael Richardson to New Position of Vice President, Business Development
Printer Friendly Version
09/27/19
Optinose to Present at the 2019 Cantor Global Healthcare Conference
Printer Friendly Version
09/26/19
OptiNose Announces License Agreement Related to ONZETRA XSAIL
Printer Friendly Version
09/17/19
Optinose Announces Departure of Chief Commercial Officer
Printer Friendly Version
09/12/19
Optinose Announces $150 Million Debt Financing from Pharmakon
Printer Friendly Version
08/12/19
Optinose Reports Second Quarter 2019 Financial Results and Recent Operational Highlights
Printer Friendly Version
08/01/19
Optinose to Report Second Quarter 2019 Financial Results and Corporate Updates on August 12, 2019
Printer Friendly Version
06/20/19
Optinose to Present at the BMO Capital Markets Prescriptions for Success Healthcare Conference
Printer Friendly Version
06/19/19
Optinose Named a 2019 Best Place to Work by Philadelphia Business Journal
Printer Friendly Version
05/09/19
Optinose Reports First Quarter 2019 Financial Results and Recent Operational Highlights
Printer Friendly Version
04/25/19
Optinose to Report First Quarter 2019 Financial Results and Corporate Updates on May 9, 2019
Printer Friendly Version
03/06/19
Optinose Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Operational Highlights
Printer Friendly Version
02/27/19
Optinose to Report Fourth Quarter 2018 Financial Results and Corporate Updates on March 6, 2019
Printer Friendly Version
02/19/19
Optinose Announces Issuance of Four Additional U.S. Patents Covering XHANCE
Printer Friendly Version
02/15/19
Optinose to Highlight Data at the 2019 AAAAI Annual Meeting in San Francisco
Printer Friendly Version
02/04/19
Optinose Announces License Agreement
Printer Friendly Version

Investors


Toolkit